NCT06718933 2025-02-06
Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain Metastasis
Fudan University
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT06015048 2024-08-05
A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2 Recruiting
NCT03772353 2023-03-07
PLEASURABLE
Fudan University
Phase 1/2 Unknown
NCT04582968 2023-01-18
Pyrotinib Combined With Brain Radiotherapy in Breast Cancer Patients With Brain Metastases
Fudan University
Phase 1/2 Unknown
NCT03805399 2022-08-10
FUTURE
Fudan University
Phase 1/2 Unknown
NCT04227041 2020-01-14
A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer
Qingdao Zhixin Health Technology Co., Ltd.
Phase 1/2 Unknown